{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:34:33Z","timestamp":1792668873090,"version":"4.5.0"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.9255","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T12:12:47Z","timestamp":1367410367000},"page":"993-998","source":"Crossref","is-referenced-by-count":18,"title":["Use of Corticosteroids in the Treatment of Cholesterol Crystal Embolism after Cardiac Catheterization: A Report of Four Japanese Cases"],"prefix":"10.2169","volume":"52","author":[{"given":"Jun","family":"Masuda","sequence":"first","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tanigawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Nakamori","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Sawai","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashio","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Lye WC, Cheah JS, Sinniah R, et al. Renal cholesterol embolic disease: Case report and review of the literature. Am J Nephrol 13: 489-493, 1993."},{"key":"2","unstructured":"2. Fine MJ, Kapoor W, Falanga V. Choleterol crystal embolization: A review of 221 cases in the English literature. Angiology 38: 769-984, 1987."},{"key":"3","unstructured":"3. Flory CM. Arterial occlusions produced by emboli from eroded aortic athromatous plaques. Am J Pathol 21: 549-565, 1945."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Funabiki K, Masuoka H, Shimizu H, et al. Cholesterol crystal embolization(CCE) after cardiac catheterization. Jpn Heart J 44: 767-774, 2003.","DOI":"10.1536\/jhj.44.767"},{"key":"5","unstructured":"5. Scolari F, Ravani P, Pola A, et al. Predictors of renal and patients outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol 14: 1584-1590, 2003."},{"key":"6","unstructured":"6. Scolari F, Tardanico R, Zani R, et al. Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 36: 1089-1109, 2000."},{"key":"7","unstructured":"7. Thadhani RI, Camargo CA, Xavier RJ, et al. Atheroembolic renal failure after invasive procedures: Natural history based on 52 histologically proven cases. Medicine (Baltimore) 74: 350-358, 1995."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lye WC, Cheah JS, Sinniah R. Renal cholesterol embolic disease. Case report and review of the literature. Am J Nephrol 13: 489-493, 1993.","DOI":"10.1159\/000168669"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 33: 840-850, 1999.","DOI":"10.1016\/S0272-6386(99)70415-4"},{"key":"10","unstructured":"10. Drost H, Buis B, Haan D, Hillers JA. Cholesterol embolism as a complication of left heart catheterization: Report of seven cases. Br Heart J 52: 339-342, 1984."},{"key":"11","unstructured":"11. Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 42: 211-216, 2003."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Daimon S, Motita R, Ohtsuki N, et al. LDL apheresis followed by corticosteroid therapy as a possible treatment of cholesterol crystal embolism. Clin Exp Nephrol 4: 352-355, 2000.","DOI":"10.1007\/s101570070015"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakahama H, Sakaguchi K. Small dose oral corticosteroid treatment rapidly improved renal function in a patient with acute aggravation of chronic renal failure due to cholesterol embolism. Neohrol Dial Transplant 16: 872-873, 2001.","DOI":"10.1093\/ndt\/16.4.872"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tamura K, Umemura M, Yano H, et al. Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan. Clin Exp Nephrol 7: 67-71, 2003.","DOI":"10.1007\/s101570300010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nakayama M, Nagata M, Hirano T, et al. Low-dose prednisolone ameliorates acute renal failure caused by cholesterol crystal embolism. Clin Nephrol 66: 232-239, 2006.","DOI":"10.5414\/CNP66232"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nakayama M, Izumaru K, Nagata M, et al. The effect of low-dose corticosteroids on short- and long-term renal outcome in patients with cholesterol crystal embolism. Renal Failure 33: 298-306, 2011.","DOI":"10.3109\/0886022X.2011.560403"},{"key":"17","unstructured":"17. Jones DB, Iannaccone PM. Atheromatous emboli in renal biopsies. An ultrastructural study. Am J Pathol 78: 261-276, 1975."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Cheng C, Tsuneyama K, Zheng H, et al. Enhanced scavenging of lipid substances is a possible effect of corticosteroids in the treatment of cholesterol crystal embolism. Pathol Res Pract 202: 591-598, 2006.","DOI":"10.1016\/j.prp.2006.04.005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fabbian F, Catalano C, Lambertini D, et al. A possible role of corticosteroids in cholesterol embolization. Nephron 83: 189-190, 1999.","DOI":"10.1159\/000045509"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mann SJ, Sos TA. Treatment of atheroembolization with corticosteroids. Am J Hypertens 14: 831-834, 2001.","DOI":"10.1016\/S0895-7061(01)02183-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Graziani G, Santostasi S, Angelini C, et al. Corticosteroids in cholesterol emboli syndrome. Nephron 87: 371-373, 2001.","DOI":"10.1159\/000045946"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hasegawa M, Kawashima S, Shikano M, et al. The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. Am J Nephrol 20: 263-267, 2000.","DOI":"10.1159\/000013598"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Tsunoda S, Daimon S, Miyazaki R, et al. LDL apheresis as intensive lipid-lowering therapy for cholesterol embolism. Nephrol Dial Transplant 14: 1041-1042, 1999.","DOI":"10.1093\/ndt\/14.4.1041b"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hasegawa M, Sugiyama S. Apheresis in the treatment of cholesterol embolic disease. Ther Apher Dial 7: 435-438, 2003.","DOI":"10.1046\/j.1526-0968.2003.00081.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/9\/52_52.9255\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:49:16Z","timestamp":1621446556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/9\/52_52.9255\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.9255","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}